DE60121166D1 - 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette - Google Patents

4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Info

Publication number
DE60121166D1
DE60121166D1 DE60121166T DE60121166T DE60121166D1 DE 60121166 D1 DE60121166 D1 DE 60121166D1 DE 60121166 T DE60121166 T DE 60121166T DE 60121166 T DE60121166 T DE 60121166T DE 60121166 D1 DE60121166 D1 DE 60121166D1
Authority
DE
Germany
Prior art keywords
hydroxybutylidene
amino
compressed tablet
directly compressed
acid directly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60121166T
Other languages
English (en)
Inventor
Dagmar Jasprova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121166(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentiva KS filed Critical Zentiva KS
Application granted granted Critical
Publication of DE60121166D1 publication Critical patent/DE60121166D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
DE60121166T 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette Expired - Fee Related DE60121166D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20002567A CZ289261B6 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PCT/CZ2001/000037 WO2002003963A1 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient

Publications (1)

Publication Number Publication Date
DE60121166D1 true DE60121166D1 (de) 2006-08-10

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121166T Expired - Fee Related DE60121166D1 (de) 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Country Status (17)

Country Link
US (1) US7198802B2 (de)
EP (1) EP1299088B1 (de)
AT (1) ATE331502T1 (de)
AU (1) AU2001270454A1 (de)
BG (1) BG107520A (de)
CA (1) CA2415630A1 (de)
CZ (1) CZ289261B6 (de)
DE (1) DE60121166D1 (de)
EE (1) EE200300017A (de)
HR (1) HRP20020735A2 (de)
HU (1) HUP0301072A3 (de)
PL (1) PL360872A1 (de)
RU (1) RU2279273C2 (de)
SK (1) SK283249B6 (de)
UA (1) UA73784C2 (de)
WO (1) WO2002003963A1 (de)
YU (1) YU77702A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
EP1499295A4 (de) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co Metoprolol-formulierungen mit verzögerter freisetzung
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
EP1781258A1 (de) * 2004-08-20 2007-05-09 Mepha AG Formulierungen von biphosphonaten
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
JP5424642B2 (ja) * 2005-10-27 2014-02-26 ニクリス アーゲー インプラント及びその製造方法
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
MX2011002016A (es) * 2008-08-22 2011-05-19 Wockhardt Research Center Composición farmacéutica de dosis oral en una sola unidad, que comprende levodopa, carbidopa y entacapona, o sales.
EA201190243A1 (ru) * 2009-05-19 2013-01-30 Гриндекс, Э Джоинт Сток Кампани Стабильная фармацевтическая композиция флударабина фосфата
DK2512455T3 (en) 2009-12-18 2014-03-24 Frieslandcampina Nederland Holding B V Co-treated tablet adjuvant composition, its preparation and use
WO2023025672A1 (en) 2021-08-25 2023-03-02 Basf Se Direct tableting auxiliary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
EP0697890A1 (de) * 1993-05-15 1996-02-28 Roche Diagnostics GmbH Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
KR20010005746A (ko) 1997-03-26 2001-01-15 더글라스이.리디치 화학적, 열적으로 안정적인 노라스테미졸 조성물
HUP0300419A3 (en) * 2000-04-07 2005-07-28 Pfizer Prod Inc Estrogen agonist/antagonist metabolites, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
PL360872A1 (en) 2004-09-20
WO2002003963A1 (en) 2002-01-17
YU77702A (sh) 2006-05-25
UA73784C2 (en) 2005-09-15
CZ20002567A3 (cs) 2001-12-12
BG107520A (bg) 2003-06-30
SK5112001A3 (en) 2002-02-05
US20030161878A1 (en) 2003-08-28
RU2279273C2 (ru) 2006-07-10
EE200300017A (et) 2004-10-15
HUP0301072A3 (en) 2005-07-28
ATE331502T1 (de) 2006-07-15
SK283249B6 (sk) 2003-04-01
HRP20020735A2 (en) 2004-12-31
CA2415630A1 (en) 2002-01-17
CZ289261B6 (cs) 2001-12-12
EP1299088A1 (de) 2003-04-09
EP1299088B1 (de) 2006-06-28
HUP0301072A2 (hu) 2003-08-28
AU2001270454A1 (en) 2002-01-21
US7198802B2 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
DE60121166D1 (de) 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette
HRP20040996B1 (en) High drug load tablet
NZ507271A (en) Fast disintegrating tablets
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
JP2002511411A5 (de)
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
WO2001072728A3 (en) Novel piperazine derivatives
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO1999055332A8 (fr) Compositions medicinales
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
EP1219296A4 (de) Mittel zur hemmung der sebumproduktion
IT1273790B (it) Derivati eterociclici diazotati aventi attivita' aii antagonista
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
EP0503079A4 (en) Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee